|
?:authorAffiliation
|
-
[\'Parkinson\'s Disease and Movement Disorders, Shirley Ryan AbilityLab and Departments of Physical Medicine and Rehabilitation and Neurology, Northwestern University Feinberg School of Medicine, 355 E. Erie Street, Chicago, IL, USA. jgoldman02@sralab.org.\', \'Department of Neurology, Mayo Clinic, Rochester, MN, USA.\', \'Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA.\', \'Department of Neurosciences, UC San Diego, San Diego, CA, USA.\', \'Comprehensive Center for Brain Health, Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.\', \'Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.\', \'Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.\', \'Department of Neurology, Taub Institute, Sergievsky Center, Columbia University Irving Medical Center, New York, NY, USA.\', \'Acadia Pharmaceuticals, San Diego, CA, USA.\', \'Neuroscience Research, Eli Lilly and Company, Indianapolis, IN, USA.\', \'Neurology Business Group, Eisai, Inc., Woodcliff Lake, NJ, USA.\', \'Lewy Body Dementia Association, S.W, Lilburn, GA, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}